380 related articles for article (PubMed ID: 11309341)
41. Prognostic value of uPA, PAI-1, and DNA content in adult renal cell carcinoma.
Chautard D; Dalifard I; Chassevent A; Guyetant S; Daver A; Vielle B; Soret JY
Urology; 2004 Jun; 63(6):1055-60. PubMed ID: 15183949
[TBL] [Abstract][Full Text] [Related]
42. Flow cytometry in primary breast carcinomas: prognostic impact of S-phase fraction according to different analysis patterns.
Michels JJ; Marnay J; Plancoulaine B; Chasle J
Cytometry B Clin Cytom; 2004 May; 59(1):32-9. PubMed ID: 15108168
[TBL] [Abstract][Full Text] [Related]
43. Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates.
Baldetorp B; Bendahl PO; Fernö M; Alanen K; Delle U; Falkmer U; Hansson-Aggesjö B; Höckenström T; Lindgren A; Mossberg L
Cytometry; 1995 Jun; 22(2):115-27. PubMed ID: 7587742
[TBL] [Abstract][Full Text] [Related]
44. S-phase fraction as an independent prognostic factor of long-term overall survival in patients with early-stage or locally advanced invasive breast carcinoma.
Vielh P; Carton M; Padoy E; de Rycke Y; Klijanienko J; El-Naggar AK; Asselain B
Cancer; 2005 Dec; 105(6):476-82. PubMed ID: 16116603
[TBL] [Abstract][Full Text] [Related]
45. Stratification of the biologic aggressiveness of non-small cell lung cancer using DNA flow cytometry and immunohistochemistry for the retinoblastoma protein.
Otsuka H; Funai S; Tanaka A; Hara S; Shiozaki H
Lung Cancer; 2004 Sep; 45(3):307-16. PubMed ID: 15301871
[TBL] [Abstract][Full Text] [Related]
46. Prognostic value of DNA ploidy in breast cancer stage I-II.
Cufer T; Lamovec J; Bracko M; Lindtner J; Us-Krasovec M
Neoplasma; 1997; 44(2):127-32. PubMed ID: 9201293
[TBL] [Abstract][Full Text] [Related]
47. Multiparametric deoxyribonucleic acid and cell cycle analysis of breast carcinomas by flow cytometry. Clinicopathologic correlations.
Visscher DW; Zarbo RJ; Jacobsen G; Kambouris A; Talpos G; Sakr W; Crissman JD
Lab Invest; 1990 Mar; 62(3):370-8. PubMed ID: 1690316
[TBL] [Abstract][Full Text] [Related]
48. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
Pinto AE; André S; Soares J
J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
[TBL] [Abstract][Full Text] [Related]
49. Prognostic significance of cell kinetics in laryngeal squamous cell carcinoma: clinicopathological associations.
Tomasino RM; Daniele E; Bazan V; Morello V; Tralongo V; Nuara R; Nagar C; Salvato M; Ingria F; Restivo S
Cancer Res; 1995 Dec; 55(24):6103-8. PubMed ID: 8521400
[TBL] [Abstract][Full Text] [Related]
50. [DNA analysis by flow cytometry in breast carcinoma].
Tsuchiya A; Sekikawa K; Sato H; Ando Y; Suzuki S; Nihei M; Rokkaku Y; Nomizu T; Kimijima I; Abe R
Gan No Rinsho; 1989 Jan; 35(1):30-4. PubMed ID: 2921806
[TBL] [Abstract][Full Text] [Related]
51. Flow cytometric analysis of DNA ploidy and S-phase fraction in primary localized myxofibrosarcoma: correlations with clinicopathological factors, Skp2 expression, and patient survival.
Huang HY; Huang WW; Wu JM; Huang CK; Wang JW; Eng HL; Lin CN; Chou SC; Yu SC; Fang FM; Lee JC; Li CF
Ann Surg Oncol; 2008 Aug; 15(8):2239-49. PubMed ID: 18516647
[TBL] [Abstract][Full Text] [Related]
52. Prognostic significance of DNA ploidy and proliferative indices in patients with nasopharyngeal carcinoma.
Ma J; Nicholas ; Terry HA; Lin SX; Patel N; Mai HG; Hong MH; Lu TX; Cui NJ; Min HQ
Ai Zheng; 2002 Jun; 21(6):644-50. PubMed ID: 12452067
[TBL] [Abstract][Full Text] [Related]
53. Recruitment with high physiological doses of estradiol preceding chemotherapy: flow cytometric and therapeutic results in women with locally advanced breast cancers--a Southwest Oncology Group study.
Fabian CJ; Kimler BF; McKittrick R; Park CH; Lin F; Krishnan L; Jewell WR; Osborne CK; Martino S; Hutchins LF
Cancer Res; 1994 Oct; 54(20):5357-62. PubMed ID: 7923165
[TBL] [Abstract][Full Text] [Related]
54. The clinical relevance of ploidy and S-phase fraction determination in salivary gland tumors: a flow cytometric study of 97 cases.
Pinto AE; Fonseca I; Soares J
Cancer; 1999 Jan; 85(2):273-81. PubMed ID: 10023692
[TBL] [Abstract][Full Text] [Related]
55. The flow-cytometric analysis of DNA content and S-phase fraction (SPF) of human breast cancer.
Eskelinen M; Nordling S; Puittinen J; Pesonen E; Collan Y
Pathol Res Pract; 1989 Nov; 185(5):694-7. PubMed ID: 2626377
[TBL] [Abstract][Full Text] [Related]
56. Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer.
Hedley DW; Rugg CA; Gelber RD
Cancer Res; 1987 Sep; 47(17):4729-35. PubMed ID: 3621170
[TBL] [Abstract][Full Text] [Related]
57. The prognostic significance of the S-phase fraction and DNCA ploidy in node-negative estrogen receptor-positive breast cancer.
Tolentino RS; Ang SD; Cajacom CC; Eufemio GG; Talla V; Lo RW
Philipp J Surg Spec; 1998; 53(1):25-30. PubMed ID: 12322635
[TBL] [Abstract][Full Text] [Related]
58. Association between flow cytometric S-phase fraction and apoptotic rate in breast cancer.
Samoszuk MK; Sallash G; Chen K; Carlton E; Oldaker T
Cytometry; 1996 Dec; 26(4):281-5. PubMed ID: 8979027
[TBL] [Abstract][Full Text] [Related]
59. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
[TBL] [Abstract][Full Text] [Related]
60. TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma.
Russo A; Corsale S; Agnese V; Macaluso M; Cascio S; Bruno L; Surmacz E; Dardanoni G; Valerio MR; Vieni S; Restivo S; Fulfaro F; Tomasino RM; Gebbia N; Bazan V
J Cell Physiol; 2006 Jan; 206(1):181-8. PubMed ID: 15965904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
